0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Journal Articles

in Cutaneous T-cell Lymphoma

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
Related JAMA Internal Medicine Collections
From The JAMA Network
JAMA Oncology
Brief Report  | 
Durable Responses With Maintenance Dose-Sparing Regimens of Romidepsin in Cutaneous T-Cell Lymphoma
M. Estela Martinez-Escala, MD; Timothy M. Kuzel, MD; Jason B. Kaplan, MD; et al.
JAMA Oncology
Invited Commentary  | 
Romidepsin Therapy Over 5 Years in a Clinical Setting—Real-World Experience
Susan E. Bates, MD; Larisa J. Geskin, MD
JAMA Dermatology
Observation  | 
Cutaneous T-Cell Lymphoma Misdiagnosed as Lipodermatosclerosis
W. James Tidwell, MD; Janine Malone, MD; Jeffrey P. Callen, MD
JAMA Dermatology
Research Letter  | 
Efficacy and Safety of APO866 in Patients With Refractory or Relapsed Cutaneous T-Cell Lymphoma A Phase 2 Clinical Trial
Simone M. Goldinger, MD; Sharon Gobbi Bischof, MD; Regina Fink-Puches, MD; et al.